Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancerAlexios Matikas, Jonas Bergh, Mats Hellström et al.|Breast Cancer Research and Treatment|2017Cited by 8